𝔖 Bobbio Scriptorium
✦   LIBER   ✦

39 Co-ordinate overexpression of urokinase receptor and αvβ5 vitronectin receptor in breast cancer

✍ Scribed by M.V. Carriero; S. Del Vecchio; P. Franco; M. Capozzoli; L. Corvino; M.I. Potena; A. Zannetti; M.P. Stoppelli; M. Salvatore

Book ID
117439416
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
131 KB
Volume
11
Category
Article
ISSN
0268-9499

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Engaged urokinase receptors enhance tumo
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating αvβ5 vitronectin receptor cell surface expression
✍ Immacolata Silvestri; Immacolata Longanesi Cattani; Paola Franco; Giuseppe Piroz 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 831 KB

## Abstract We have previously shown that urokinase receptor physically and functionally interacts with αvβ5 vitronectin receptor, leading to tumor breast cell migration and invasion. Here, the link between these 2 receptors was further investigated by analyzing the expression levels of urokinase r

Overexpression of urokinase receptor in
Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
✍ Rosie Hongmei Xing; Shafaat Ahmed Rabbani 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 753 KB

We have examined the role of urokinase receptor (uPAR) in tumor invasion and metastasis by developing a homologous model of uPAR overexpression in a rat breast cancer cell line (Mat B III) using gene transfer technique. Control (pRc-CMV) and experimental plasmid (pRc-uPAR-S) were transfected into Ma

Overexpression of both TFPIα and TFPIβ i
Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
✍ Benedicte Stavik; Grethe Skretting; Marit Sletten; Per Morten Sandset; Nina Iver 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

## Abstract Thrombosis is a major complication and an important cause of death in cancer patients. Tumor cells may trigger coagulation and induce a prothrombotic phenotype, which in return may enhance angiogenesis, tumor growth, and metastasis. Tissue factor pathway inhibitor (TFPI) has been report